ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC15104-10mM (in 1mL DMSO) |
|
828934-41-4 |
(R)-(+)-Etomoxir sodium salt
|
0 | C15H18ClNaO4 | |
GC15104-50mg |
|
828934-41-4 |
(R)-(+)-Etomoxir sodium salt
|
0 | C15H18ClNaO4 | |
GC15104-10mg |
|
828934-41-4 |
(R)-(+)-Etomoxir sodium salt
|
0 | C15H18ClNaO4 | |
GC15102-25mg |
|
1700663-41-7 |
EPZ020411
|
0 | C25H38N4O3 | |
GC15102-10mg |
|
1700663-41-7 |
EPZ020411
|
0 | C25H38N4O3 | |
GC15102-5mg |
|
1700663-41-7 |
EPZ020411
|
0 | C25H38N4O3 | |
GC15101-10mM (in 1mL DMSO) |
|
123524-52-7 |
Azelnidipine
|
0 | C33H34N4O6 | |
GC15101-10mg |
|
123524-52-7 |
Azelnidipine
|
0 | C33H34N4O6 | |
GC15101-5mg |
|
123524-52-7 |
Azelnidipine
|
0 | C33H34N4O6 | |
GC15099-10mg |
|
167114-91-2 |
Autocamtide-2-related inhibitory peptide
|
0 | C78 H142 N22 O20 . C2 H F3 O2 | |
GC15099-5mg |
|
167114-91-2 |
Autocamtide-2-related inhibitory peptide
|
0 | C78 H142 N22 O20 . C2 H F3 O2 | |
GC15099-1mg |
|
167114-91-2 |
Autocamtide-2-related inhibitory peptide
|
0 | C78 H142 N22 O20 . C2 H F3 O2 | |
GC15098-10mM (in 1mL DMSO) |
|
77-86-1 |
Trometamol
|
0 | C4H11NO3 | |
GC15098-50mg |
|
77-86-1 |
Trometamol
|
0 | C4H11NO3 | |
GC15096-100mg |
|
53518-15-3 |
7-Amino-4-(trifluoromethyl)coumarin
|
0 | C₁₀H₆F₃NO₂ | |
GC15095-10mM (in 1mL Water) |
|
59-92-7 |
Levodopa
|
0 | C9H11NO4 | |
GC15095-200mg |
|
59-92-7 |
Levodopa
|
0 | C9H11NO4 | |
GC15095-1g |
|
59-92-7 |
Levodopa
|
0 | C9H11NO4 | |
GC15094-50mg |
|
874902-19-9 |
LY2183240
|
0 | C17H17N5O | |
GC15094-10mg |
|
874902-19-9 |
LY2183240
|
0 | C17H17N5O | |